Junshi Biosciences gets Chinese approval
for emerging therapy to treat skin cancer. 
 
	
 
 
	A Shanghai Co. has nabbed China's first
approval for a homegrown anti-PD-1 treatment, an emerging cancer therapy that
boosts the immune system to help the body to target and kill tumors.